Literature DB >> 21242995

Non-malignant B cells and chronic lymphocytic leukemia cells induce a pro-survival phenotype in CD14+ cells from peripheral blood.

N Bhattacharya, S Diener, I S Idler, T F Barth, J Rauen, A Habermann, T Zenz, P Möller, H Döhner, S Stilgenbauer, D Mertens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21242995     DOI： 10.1038/leu.2010.306

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migration.

Authors:  J Hoellenriegel; G P Coffey; U Sinha; A Pandey; M Sivina; A Ferrajoli; F Ravandi; W G Wierda; S O'Brien; M J Keating; J A Burger
Journal:  Leukemia       Date:  2012-02-07       Impact factor: 11.528

Review 2.  Inhibiting B-cell receptor signaling pathways in chronic lymphocytic leukemia.

Authors:  Jan A Burger
Journal:  Curr Hematol Malig Rep       Date:  2012-03       Impact factor: 3.952

3.  Disruption of Nurse-like Cell Differentiation as a Therapeutic Strategy for Chronic Lymphocytic Leukemia.

Authors:  Giovanna Merchand-Reyes; Ramasamy Santhanam; Frank H Robledo-Avila; Christoph Weigel; Juan de Dios Ruiz-Rosado; Xiaokui Mo; Santiago Partida-Sánchez; Jennifer A Woyach; Christopher C Oakes; Susheela Tridandapani; Jonathan P Butchar
Journal:  J Immunol       Date:  2022-08-22       Impact factor: 5.426

Review 4.  Coming full circle: 70 years of chronic lymphocytic leukemia cell redistribution, from glucocorticoids to inhibitors of B-cell receptor signaling.

Authors:  Jan A Burger; Emili Montserrat
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

Review 5.  Targeting B cell receptor signalling in cancer: preclinical and clinical advances.

Authors:  Jan A Burger; Adrian Wiestner
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

6.  Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia.

Authors:  D Allegra; V Bilan; A Garding; H Döhner; S Stilgenbauer; F Kuchenbauer; D Mertens; M Zucknick
Journal:  Leukemia       Date:  2013-08-26       Impact factor: 11.528

7.  Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples.

Authors:  David K Edwards V; David Tyler Sweeney; Hibery Ho; Christopher A Eide; Angela Rofelty; Anupriya Agarwal; Selina Qiuying Liu; Alexey V Danilov; Patrice Lee; David Chantry; Shannon K McWeeney; Brian J Druker; Jeffrey W Tyner; Stephen E Spurgeon; Marc M Loriaux
Journal:  Oncotarget       Date:  2018-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.